National Methadone Conference 2001 Sponsored by American Methadone Treatment Association

Attention: This
presentation contains pictures and takes time to download. 

Please be patient!

Opioid Treatment in the 21st Century: Implementing the Vision

St. Louis

October 7-10, 2001

St. Louis Arch

Five YEAR PLAN AVAILABLE IN POLICY MAKERS LUNCHEON SECTION

 

Advocacy Events and Patient Participation

NAMA at AMTA Conference 2001

Sunday, October 7th

Pre-conference Meeting 9 A.M. to 5 P.M.
Unifying the Treatment Community
Moderator Todd Rosendale, Center for Substance Abuse Treatment
Speakers

  • Fred Christie, AFFIRM (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

(Sponsored by the Center for Substance Abuse Treatment)

The First Patients Advocates Illumination Award 4 P.M.
Chair Todd Rosendale, Center for Substance Abuse Treatment
Presented by Joycelyn Woods, NAMA

The Advocacy Coalition will present the first patient’s Advocates Illumination Award to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment.

Presented to Dr. Marc Shinderman and the Center for Addiction Problems

(Sponsored by the Center for Substance Abuse Treatment)

Welcome Reception 6 P.M.

Monday, October 8th

Opening Address 8 A.M.

Policy Makers Luncheon 11 A.M. to 1 P.M.

Chair Mark Parrino, American Methadone Treatment Association

The Policy Maker’s Luncheon is an invitation only event that is attended by the federal and state agencies and
organizational representatives (i.e. ASAM, NAMA). The luncheon was initiated as a way to get the regulatory bodies together for discussions prior to changes in the federal regulation.

(Sponsored by the American Methadone Treatment Association)

Poster Session 2 P.M. 

The
Hepatitis C POSTER SESSION IS AVAILABLE AS POWERPOINT PRESENTATION ONLY! 

DOWNLOAD HCV PowerPoint Presentation

Hepatitis C and the Methadone Patient              
Authors

  • Tony Scro, NAMA Board of Directors (Grievance Coordinator) and ABATE (President)
  • Rokki Baker, NAMA Board of Directors (Chapter Coordinator), NAMA Nor-Cal (President) and Santa Cruz Hepatitis C Task Force
  • John Finger, NAMA (Regional Director), TexNAMA (President)
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist),TexNAMA (Vice President)

NAMA Organizational Meeting 7 P.M.
Chairs
Jo Sotheran, NAMA Board of Directors (Treasurer)
Joycelyn Woods, NAMA Board of Directors (President)

Many organizations use the conference as an opportunity to meet and NAMA is no different. Twenty-six NAMA representatives from around the country met to discuss patient advocacy issues.

Tuesday, October 9th

Hot Topic Round Table 2 P.M.
Administrative Detox: Necessary Use or Abuse
Authors

  • Joe Neuberger, Delaware NAMA (President)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee

Award Banquet 8 P.M.

The first conference of the new millennium heralds the recognition and acceptance of patient advocacy. For the first time no less than three awards were presented to patient advocates recognizing their work.

Wednesday, October 10th

Workshop 8 A.M.
Past, Present and Future: A Selection of Unfinished Business in Methadone Treatment
Authors

  • Moderator, Howard Lotsof, NAMA Acting Membership Director
  • Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President)
  • Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

Press Conference 12 P.M.
Director Jeanne Henry, Office of Public Affairs, Sate of Missouri, Department of Mental Health

Patient Advocacy Interviews Organized by Norma Alexander, NAMA Media Director
Interviews

  • Joycelyn Woods, NAMA Board of Directors (President)
  • Howard Lotsof, NAMA Acting Membership Director
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist) and TexNAMA (Vice President)

Sponsored by State of Missouri, Department of Mental Health

Closing Address 12 P.M.

Smoozing Around The Conference

A quick photo album of the conference.

 

NAMA HOME PAGE

Similar Posts

  • Oral Swabs

    Admin 08/23/2022

    Policy Statement Number 13 July 2003 The development of Oral Swabs for toxicology testing shows potential in providing an alternative means to test for drug use and to assess if a patient is taking their medication as prescribed. Such advances in technology should improve the quality of treatment that programs can provide to patients. However…

  • |

    OBOT Publications

    Admin 04/20/2023

    Publications Office Based Opioid Treatment Federal Code U.S. Federal Code. Confidentiality of Alcohol and Drug Abuse Patient Records. U.S. Federal Code. Medical Privacy HIPPA, National Standards to Protect the Privacy of Personal Health Information. Public Law 106-310, 106th Congress Sec. 3502. Controlled Substances Act, October 17, 2000. Physician Waiver to Prescribe, Dispense Schedule III-V Narcotic Drugs in the…

  • LAAM Warning

    Admin 07/05/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • The National Methadone Conference-1

    Admin 02/12/2023

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Honorary Patient Recognition The Honorary Methadone Patient was developed by the National Alliance of Methadone Advocates to recognize those special persons who are not patients but in addition to making significant contributions to the field do so to help patients. Dr….

  • Methadone Awareness Test – Answer Five

    Admin 12/12/2022

    FALSE!   While a significant minority of methadone patients become alcoholic, over 98% were heavy or problem drinkers prior to their introduction to heroin. The statistics for cocaine abusers are similar. Methadone maintenance is not a treatment for non-opioid drug abuse. The patient who responds best to methadone maintenance treatment is one who has a…